Literature DB >> 7929834

Proteinuria in passive Heymann nephritis is associated with lipid peroxidation and formation of adducts on type IV collagen.

T J Neale1, P P Ojha, M Exner, H Poczewski, B Rüger, J L Witztum, P Davis, D Kerjaschki.   

Abstract

Passive Heymann nephritis (PHN) is a model of human membranous nephropathy that is characterized by formation of granular subepithelial immune deposits in the glomerular capillary wall which results in complement activation. This is causally related to damage of the filtration barrier and subsequent proteinuria. The local accumulation of injurious reactive oxygen species (ROS) is a major effector mechanism in PHN. ROS may induce tissue damage by initiating lipid peroxidation (LPO). In turn, this leads to adduct formation between breakdown products of LPO with structural proteins, such as formation of malondialdehyde (MDA) or 4-hydroxynonenal-lysine adducts. To examine the role of LPO in the development of proteinuria we have localized MDA and 4-hydroxynonenal-lysine adducts in glomeruli of PHN rats by immunofluorescence microscopy, using specific monoclonal antibodies. By immunogold electron microscopy, MDA adducts were localized to cytoplasmic vesicles and cell membranes of glomerular epithelial cells, to the glomerular basement membrane (GBM), and also to immune deposits. Type IV collagen was specifically identified as being modified by MDA adducts, using a variety of techniques. Collagenase pretreatment of GBM extracts indicated that the NC-1 domain of type IV collagen was a site of adduct formation. When LPO was inhibited by pretreatment of PHN rats with the antioxidant probucol, proteinuria was reduced by approximately 85%, and glomerular immunostaining for dialdehyde adducts was markedly reduced, even though the formation of immune deposits was not affected. By contrast, lowering of the serum cholesterol levels had no influence on the development of proteinuria. These findings are consistent with the premise that ROS-induced glomerular injury in PHN involves LPO and that this results not only in damage of cell membranes but in modification of type IV collagen in the GBM as well. The close temporal correlation of the occurrence of LPO with proteinuria and the ability of probucol to inhibit proteinuria support a causal role for LPO in the the alteration of the glomerular permselectivity which results in proteinuria.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7929834      PMCID: PMC295315          DOI: 10.1172/JCI117499

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  Molecular genetics of hereditary nephritis.

Authors:  S T Reeders
Journal:  Kidney Int       Date:  1992-09       Impact factor: 10.612

2.  Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum.

Authors:  W Richmond
Journal:  Clin Chem       Date:  1973-12       Impact factor: 8.327

3.  Identification of a major sialoprotein in the glycocalyx of human visceral glomerular epithelial cells.

Authors:  D Kerjaschki; H Poczewski; G Dekan; R Horvat; E Balzar; N Kraft; R C Atkins
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

Review 4.  Immunoelectron microscopy in kidney research: some contributions and limitations.

Authors:  D Kerjaschki; H Sawada; M G Farquhar
Journal:  Kidney Int       Date:  1986-08       Impact factor: 10.612

Review 5.  Role of oxidised low density lipoprotein in atherogenesis.

Authors:  J L Witztum
Journal:  Br Heart J       Date:  1993-01

Review 6.  Lipoprotein oxidation and lipoprotein-induced cell injury in diabetes.

Authors:  G M Chisolm; K C Irwin; M S Penn
Journal:  Diabetes       Date:  1992-10       Impact factor: 9.461

7.  Reactive oxygen species and neutrophil respiratory burst cytochrome b558 are produced by kidney glomerular cells in passive Heymann nephritis.

Authors:  T J Neale; R Ullrich; P Ojha; H Poczewski; A J Verhoeven; D Kerjaschki
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

8.  Glucocorticoid activates glomerular antioxidant enzymes and protects glomeruli from oxidant injuries.

Authors:  T Kawamura; T Yoshioka; T Bills; A Fogo; I Ichikawa
Journal:  Kidney Int       Date:  1991-08       Impact factor: 10.612

9.  Molecular cloning of the human Goodpasture antigen demonstrates it to be the alpha 3 chain of type IV collagen.

Authors:  N Turner; P J Mason; R Brown; M Fox; S Povey; A Rees; C D Pusey
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

10.  Identification of a pathogenic epitope involved in initiation of Heymann nephritis.

Authors:  D Kerjaschki; R Ullrich; K Diem; S Pietromonaco; R A Orlando; M G Farquhar
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

View more
  40 in total

1.  Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma.

Authors:  W Palinski; S Hörkkö; E Miller; U P Steinbrecher; H C Powell; L K Curtiss; J L Witztum
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

2.  Melanocortin 1 receptor agonists reduce proteinuria.

Authors:  Annika Lindskog; Kerstin Ebefors; Martin E Johansson; Bergur Stefánsson; Anna Granqvist; Margret Arnadottir; Anna-Lena Berg; Jenny Nyström; Börje Haraldsson
Journal:  J Am Soc Nephrol       Date:  2010-05-27       Impact factor: 10.121

Review 3.  Experimental membranous nephropathy redux.

Authors:  Andrey V Cybulsky; Richard J Quigg; David J Salant
Journal:  Am J Physiol Renal Physiol       Date:  2005-10

Review 4.  The role of innate immunity in atherogenesis.

Authors:  Karsten Hartvigsen; Meng-Yun Chou; Lotte F Hansen; Peter X Shaw; Sotirios Tsimikas; Christoph J Binder; Joseph L Witztum
Journal:  J Lipid Res       Date:  2008-12-22       Impact factor: 5.922

5.  Immunological evidence for hypochlorite-modified proteins in human kidney.

Authors:  E Malle; C Woenckhaus; G Waeg; H Esterbauer; E F Gröne; H J Gröne
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

6.  Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein.

Authors:  S Hörkkö; E Miller; E Dudl; P Reaven; L K Curtiss; N J Zvaifler; R Terkeltaub; S S Pierangeli; D W Branch; W Palinski; J L Witztum
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

7.  Short term statin treatment improves survival and differentially regulates macrophage-mediated responses to Staphylococcus aureus.

Authors:  Erin M Burns; Lisa K Smelser; Jenny E Then; Traci E Stankiewicz; Michael Kushdilian; Susan A McDowell; Heather A Bruns
Journal:  Curr Pharm Biotechnol       Date:  2013       Impact factor: 2.837

Review 8.  Redox control of renal function and hypertension.

Authors:  Ravi Nistala; Adam Whaley-Connell; James R Sowers
Journal:  Antioxid Redox Signal       Date:  2008-12       Impact factor: 8.401

Review 9.  [Membranous glomerulonephritis].

Authors:  S Scheidat; R A K Stahl
Journal:  Internist (Berl)       Date:  2003-09       Impact factor: 0.743

10.  Urinary and glomerular podocytes in patients with chronic kidney diseases.

Authors:  Kikuno Hanamura; Akihiro Tojo; Toshiro Fujita
Journal:  Clin Exp Nephrol       Date:  2013-05-15       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.